Industry NewsLife Sciences QIAGEN expands portfolio for minimal residual disease testing in oncology with new strategic partnerships
Product NewsLife Sciences QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions
Industry NewsLife Sciences QIAGEN expands its Digital PCR portfolio with new lentivirus solutions to strengthen cell and gene therapy quality control
Application NoteOptimized urine liquid biopsy workflow: From sample collection to cfDNA stabilization and purification, ready for digital PCR analysis
Industry NewsQIAGEN expands portfolio for minimal residual disease testing in oncology with new strategic partnerships
Industry NewsQIAGEN expands its Digital PCR portfolio with new lentivirus solutions to strengthen cell and gene therapy quality control
